NLTX · Categories · Form 4

NLTX - SEC Form 4 insider transactions

Neoleukin Therapeutics Inc. (NLTX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for NLTX

• 874d
  SEC Form 4 filed by Woods Robert Keith

  4 - Neurogene Inc. (0001404644) (Issuer)
• 874d
  SEC Form 4 filed by Palekar Rohan

  4 - Neurogene Inc. (0001404644) (Issuer)
• 874d
  SEC Form 4 filed by Noonberg Sarah B.

  4 - Neurogene Inc. (0001404644) (Issuer)
• 874d
  SEC Form 4 filed by Freedland Cory S.

  4 - Neurogene Inc. (0001404644) (Issuer)
• 874d
  SEC Form 4 filed by Baffi Robert

  4 - Neurogene Inc. (0001404644) (Issuer)
• 874d
  SEC Form 4 filed by Jordan Julie

  4 - Neurogene Inc. (0001404644) (Issuer)
• 903d
  SEC Form 4 filed by Baker Bros. Advisors Lp

  4 - Neurogene Inc. (0001404644) (Issuer)
• 974d
  Baker Bros. Advisors Lp converted options into 592,650 shares (SEC Form 4)

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1028d
  SEC Form 4: Baker Bros. Advisors Lp bought $1,463,487 worth of shares (2,285,342 units at $0.64)

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1031d
  SEC Form 4: Smith Sean Michael converted options into 5,000 shares and sold $818 worth of shares (1,323 units at $0.62), increasing direct ownership by 20% to 21,637 units

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1094d
  SEC Form 4 filed by Baker Bros. Advisors Lp

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1097d
  SEC Form 4 filed by Simpson Todd E

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1097d
  SEC Form 4 filed by Palekar Rohan

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1097d
  SEC Form 4 filed by Noonberg Sarah B.

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1097d
  SEC Form 4 filed by Lavelle Erin

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1097d
  SEC Form 4 filed by Babler Martin

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1163d
  SEC Form 4 filed by Patel Priti

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1223d
  SEC Form 4: Smith Sean Michael converted options into 12,500 shares and sold $1,980 worth of shares (3,316 units at $0.60), increasing direct ownership by 136% to 15,960 units to cover taxes

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1223d
  SEC Form 4: Patel Priti converted options into 35,000 shares and sold $8,588 worth of shares (14,380 units at $0.60), increasing direct ownership by 197% to 31,082 units to cover withholding tax

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1398d
  SEC Form 4: Smith Sean Michael sold $1,641 worth of shares (1,655 units at $0.99) and converted options into 5,000 shares, increasing direct ownership by 97% to 6,776 units (withholding obligation)

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1406d
  SEC Form 4 filed by Walkey Carl

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1406d
  SEC Form 4 filed by Smith Sean Michael

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1406d
  SEC Form 4 filed by Patel Priti

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1406d
  SEC Form 4 filed by Drachman Jonathan G

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1406d
  SEC Form 4 filed by Cochener Donna

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1486d
  SEC Form 4 filed by Lavelle Erin

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1486d
  SEC Form 4 filed by Simpson Todd E

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1486d
  SEC Form 4 filed by Palekar Rohan

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1486d
  SEC Form 4 filed by Noonberg Sarah B.

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1486d
  SEC Form 4 filed by Babler Martin

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1486d
  SEC Form 4 filed by Baker Bros. Advisors Lp

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1499d
  SEC Form 4: Patel Priti converted options into 10,000 shares and sold $6,749 worth of shares (5,538 units at $1.22), increasing direct ownership by 223% to 6,462 units (withholding tax)

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1548d
  SEC Form 4 filed by Cochener Donna

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1559d
  SEC Form 4 filed by Palekar Rohan

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1560d
  SEC Form 4 filed by Smith Sean Michael

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1589d
  SEC Form 4 filed by Walkey Carl

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1589d
  SEC Form 4 filed by Patel Priti

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1589d
  SEC Form 4 filed by Ho Robert

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1749d
  SEC Form 4: Drachman Jonathan G bought $933,550 worth of Common Stock (150,000 units at $6.22), increasing direct ownership by 4% to 2,348,686 units

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1770d
  SEC Form 4 filed by Neoleukin Therapeutics, Inc.

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1770d
  SEC Form 4 filed by Neoleukin Therapeutics, Inc.

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1770d
  SEC Form 4 filed by Ho Robert

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1819d
  SEC Form 4: Walkey Carl sold $6,114 worth of Common Stock (600 units at $10.19), decreasing direct ownership by 0.04% to 1,352,489 units

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1825d
  SEC Form 4: Walkey Carl sold $7,036 worth of Common Stock (650 units at $10.82), decreasing direct ownership by 0.05% to 1,353,089 units

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1827d
  SEC Form 4: Walkey Carl sold $6,600 worth of Common Stock (600 units at $11.00), decreasing direct ownership by 0.04% to 1,353,739 units

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1829d
  SEC Form 4: Walkey Carl sold $6,000 worth of Common Stock (600 units at $10.00), decreasing direct ownership by 0.04% to 1,354,339 units

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1829d
  SEC Form 4 filed by Neoleukin Therapeutics, Inc.

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1841d
  SEC Form 4: Walkey Carl sold $6,000 worth of Common Stock (600 units at $10.00), decreasing direct ownership by 0.04% to 1,354,939 units

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1854d
  SEC Form 4 filed by Williams Lewis T

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1854d
  SEC Form 4 filed by SIMPSON TODD E

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1854d
  SEC Form 4 filed by Noonberg Sarah B.

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1854d
  SEC Form 4 filed by Lavelle Erin M.

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1854d
  SEC Form 4 filed by Babler Martin

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1854d
  SEC Form 4 filed by BAKER BROS. ADVISORS LP

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1855d
  SEC Form 4: Walkey Carl sold $13,308 worth of Common Stock (1,200 units at $11.09), decreasing direct ownership by 0.09% to 1,354,762 units

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1861d
  SEC Form 4: Walkey Carl sold $13,560 worth of Common Stock (1,200 units at $11.30), decreasing direct ownership by 0.09% to 1,355,962 units

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1863d
  SEC Form 4 filed by Patel Priti

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1867d
  SEC Form 4: Walkey Carl sold $30,192 worth of Common Stock (2,400 units at $12.58), decreasing direct ownership by 0.18% to 1,357,162 units

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1870d
  SEC Form 4: Walkey Carl sold $7,800 worth of Common Stock (600 units at $13.00), decreasing direct ownership by 0.04% to 1,359,562 units

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)
• 1875d
  SEC Form 4: Walkey Carl sold $21,564 worth of Common Stock (1,800 units at $11.98), decreasing direct ownership by 0.13% to 1,360,162 units

  4 - Neoleukin Therapeutics, Inc. (0001404644) (Issuer)

Other NLTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends